跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
5-Aminouracil
首页
药物
5-Aminouracil
Experimental
Small Molecule
5-Aminouracil
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
4
H
5
N
3
O
2
CAS 编号
932-52-5
UNII ID
R2O7EKY9G9
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD FOR PREPARING 3,6-DIAMINOPYRAZINE-2,5-DICARBOXYLIC ACID AND SYNTHETIC INTERMEDIATE THEREOF
EP 4242209 A1
申请人: HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO LTD
优先权: 2020
CN
EP
US
WO
6 件公开
Uridine analogs and techniques for making and using
US 6987180 B2
申请人: HARVARD COLLEGE
优先权: 2002
US
2 件公开
Synthesis method of urapidil medical intermediate 1,3-dimethyl-6-(3-hydroxy propyl)aminouracil
CN 105503743 A
申请人: CHENGDU QIESITE TECH CO LTD
优先权: 2015
CN
2 件公开
Synthesis method for theophylline
CN 104744470 A
申请人: HEFEI PINGGUANG PHARMACEUTICAL CO LTD
优先权: 2014
CN
Citrate tofacitinib synthesizing method
CN 104987339 A
申请人: ZHANG YANMEI
优先权: 2015
CN
Synthetic method of fluorouracil drug intermediate 1-phthalide-5-aminouracil
CN 105481837 A
申请人: CHENGDU QIESITE TECH CO LTD
优先权: 2015
CN
Istradefylline preparation method
CN 109928973 A
申请人: SHANDONG XINHUA PHARMACEUTICAL
优先权: 2019
CN
Synthesis method of tofacitinib citrate
CN 111533746 A
申请人: ABA CHEMICALS CORP
优先权: 2020
CN
Anodic oxidation of 5-aminouracil
US 11708336 B2
申请人: MEDIBEACON INC
优先权: 2020
US
The invention relates to a method for preparing a medical intermediate pyrido [2, 3-d: 5, 6-dapos; process for the preparation of [1, 2, 3] bipyrimidine derivatives
CN 117756804 A
申请人: NANJING XINJIU MEDICINE TECH CO LTD
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈